Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.03.2021 | Case report

Hydroxychloroquine

Refractory acute generalized exanthematous pustulosis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Sanchez-Velazquez A, et al. Hydroxychloroquine-induced acute generalized exanthematous pustulosis: an adverse reaction to keep in mind during COVID-19 pandemic. Journal der Deutschen Dermatologischen Gesellschaft : no pagination, Jan 2021. Available from: URL: http://doi.org/10.1111/ddg.14354 Sanchez-Velazquez A, et al. Hydroxychloroquine-induced acute generalized exanthematous pustulosis: an adverse reaction to keep in mind during COVID-19 pandemic. Journal der Deutschen Dermatologischen Gesellschaft : no pagination, Jan 2021. Available from: URL: http://​doi.​org/​10.​1111/​ddg.​14354
Metadaten
Titel
Hydroxychloroquine
Refractory acute generalized exanthematous pustulosis: case report
Publikationsdatum
01.03.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-92783-x

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Diazoxide

Case report

Methotrexate

Case report

Sirolimus

Case report

Isoniazid